Introduction to Promacta (Eltrombopag) 5mg
Eltero™ (Eltrombopag) 5mg is a prescription medicine used to increase platelet counts in patients with thrombocytopenia caused by conditions such as chronic immune thrombocytopenia (ITP), aplastic anemia, or hepatitis C-associated thrombocytopenia. This medicine belongs to a class of drugs known as thrombopoietin receptor agonists, which stimulate platelet production in the bone marrow.
Promacta (Eltrombopag) 5mg is classified under Prescription Medicines, Hematology Drugs, Thrombopoietin Receptor Agonists, and Blood Disorder Therapies. It contains Eltrombopag, which helps restore platelet levels, reducing the risk of bleeding and improving quality of life.
In some markets, Eltero™ 5mg is available as a generic preparation containing the same active ingredient Eltrombopag, providing similar therapeutic effects under medical supervision.
What Is Promacta (Eltrombopag)?
Promacta is the original brand name for Eltrombopag, an oral thrombopoietin receptor agonist widely used for increasing platelet counts in patients with low platelet conditions.
Eltrombopag works by stimulating the thrombopoietin receptor on bone marrow cells, promoting platelet production.
Generic versions such as Eltero™ 5mg contain the same active compound and may be used depending on physician recommendation and availability.
Drug Class and Mechanism of Action
Eltrombopag is classified as a thrombopoietin receptor agonist with hematopoietic activity.
How Eltrombopag Works
It works in several ways:
- Stimulates thrombopoietin receptors in bone marrow
- Promotes production of platelets
- Reduces risk of bleeding in thrombocytopenic patients
Through these mechanisms, Eltrombopag helps restore safe platelet counts in patients with chronic low platelets.
How Promacta Works in the Body
Eltrombopag is absorbed through the gastrointestinal tract and acts primarily on the bone marrow to increase platelet production.
Key Actions of Eltrombopag
- Stimulates platelet formation
- Improves blood clotting ability
- Reduces the risk of bleeding complications
Generic versions like Eltero™ deliver the same active compound, providing similar platelet-boosting effects under appropriate supervision.
Medical Uses of Promacta (Eltrombopag) 5mg
Eltero™ for Chronic Immune Thrombocytopenia (ITP)
Used to treat patients with low platelet counts due to ITP.
Potential Benefits
- Increases platelet levels
- Reduces risk of spontaneous bleeding
- Improves patient safety and quality of life
Eltero™ for Aplastic Anemia
Effective for patients with aplastic anemia requiring platelet support.
Treatment Benefits
- Supports bone marrow recovery
- Reduces need for platelet transfusions
- Enhances overall hematologic function
Eltero™ for Hepatitis C-Associated Thrombocytopenia
Used to increase platelet counts in hepatitis C patients undergoing antiviral therapy.
Treatment Benefits
- Enables continuation of antiviral therapy
- Reduces bleeding risk during treatment
- Improves treatment outcomes
Who Can Take Eltero™ 5mg?
Eltrombopag should be used under medical supervision.
Eligibility Criteria
Patients may be prescribed Eltero™ if they:
- Have chronic ITP, aplastic anemia, or hepatitis C-associated thrombocytopenia
- Require platelet count support
- Can adhere to monitoring and dosing instructions
Who Should Avoid Promacta (Eltrombopag) 5mg
Eltrombopag should NOT be used by:
- Patients allergic to Eltrombopag or any component of the formulation
- Individuals with active liver disease unless closely monitored
- Pregnant or breastfeeding women unless advised by a doctor
Promacta (Eltrombopag) 5mg Dosage and Administration
Standard Dosage Guidelines
Typical dosage recommendations include:
- Eltero™ 5mg once daily (adjusted per doctor’s guidance)
- Take on an empty stomach, 1 hour before or 2 hours after meals
- Swallow tablets whole with water
Dosage Adjustments
Doctors may adjust the dose depending on:
- Patient platelet response
- Liver function
- Concomitant medications
Side Effects of Eltero™ 5mg
Common Side Effects
- Headache or dizziness
- Nausea or vomiting
- Fatigue or mild fever
Serious Side Effects
- Liver enzyme elevation
- Blood clot formation (rare)
- Severe allergic reactions
Patients should report any unusual symptoms to their doctor immediately.
Storage:
Store below 25°C in a cool, dry place, protected from sunlight. Keep out of reach of children.
Frequently Asked Questions (FAQs)
1. How long does it take for Eltero™ 5mg to increase platelets?
Platelet counts usually improve within 1–2 weeks of consistent therapy, under medical monitoring.
2. Can Eltero™ be used with other blood medications?
Yes, but only under strict medical supervision to avoid interactions.
3. Is Eltero™ safe during pregnancy?
Pregnancy use requires careful medical evaluation; generally avoided unless necessary.
4. Is Eltero™ the same as Promacta?
Yes, both contain Eltrombopag 5mg as the active ingredient.
5. Do I need a prescription to buy Eltero™?
Yes, it is a prescription-only medicine.
Medical Disclaimer
Disclaimer:
The information provided here is for educational purposes only and should not be considered medical advice. Eltrombopag is a prescription medicine and must be used under the supervision of a qualified healthcare professional. Always consult your doctor before starting or stopping any medication.
